Purpose: We aimed to investigate the validity of the partition model (PM) in estimating the absorbed doses to liver tumour (D T ), normal liver tissue (D NL ) and lungs (D L ), when crossfire irradiations between these compartments are being considered.
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Introduction
Hepatic cancer is the second most common cause of death from cancer worldwide (Ferlay et al., 2015) . The most common type of hepatic cancer is hepatocellular carcinoma (HCC), which derived from the main cell of the liver called hepatocyte. Transarterial radioembolization using These microspheres differ in terms of specific activity (50 Bq versus 2500 Bq per microsphere, respectively) and total number of injected microspheres (60 million versus 1.2 -8 million, respectively). Hence, they are available in fix activity of 3 GBq for SIR-Spheres ® (Sirtex, 2004) , and six different activity sizes of 3, 5, 7, 10, 15 and 20 GBq for TheraSphere ® (Nordion, 2004) . 90 Y radioembolization is commonly performed on patients in the intermediate to advanced stages of the disease, where surgical resection is no longer an option. The treatment is typically delivered to achieve a tumour absorbed dose, D T of 100 -120 Gy (Garin et al., 2015b; Dezarn et al., 2011; Kennedy et al., 2007; Salem et al., 2006) , which balances between safety and effectiveness (Kennedy et al., 2007; Salem et al., 2006) . In order to minimise the risk of radiation pneumonitis, extrahepatic shunting of the microspheres especially to the lungs is assessed, prior to the treatment, using Technetium-99m (   99m   Tc) macro-aggregated albumin (MAA) (Sirtex, 2015) . The lung shunting (LS); that is the percentage of activity taken up by the lungs with respect to the administered activity, should 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 5 be lower than 20 %, to limit the absorbed dose to the lungs, D L from exceeding the limiting dose, D L lim of 30 Gy per treatment session, and 50 Gy cumulatively (Garin et al., 2015b; Ho et al., 1997) . Moreover, a limiting normal liver dose, D NL lim of 70 Gy is recommended, in order to avoid severe impairment of the liver function following the treatment (Sirtex, 2015; Lau et al., 2012) .
In estimating these doses, the most widely used dosimetric approach is the partition model (PM) which assumes a local energy deposition with no consideration of cross-fire between the liver tumour and normal liver tissue (Garin et al., 2015b; Sirtex, 2015; Ho et al., 1996) . This assumption, however, is inaccurate as tumour vascularity has the tendency to be distributed at the periphery of the tumour (Kennedy et al., 2004; Campbell et al., 2001 Campbell et al., , 2000 Fox et al., 1991) . Thus, most of the 90 Y microspheres will be deposited at the tumour boundary rather than uniformly distributed within the tumour. Since 90 Y beta particles have a relatively long range in tissue (maximum of about 1 cm), some particles originated from the tumour will deposit energy in the normal liver tissue. In this context, the increased vascularity of the tumour surface would heighten the cross-fire irradiation.
The absorbed doses estimated using PM have been previously compared with the doses measured using an intraoperative beta probing (Ho et al., 1996) . Although correlations were found between the measured and calculated data, the discrepancies were still large with mean dose differences of 14.8 ± 14.0 and 15.1 ± 27.2 % for tumour and normal liver, respectively. Also, the highly invasive approach is considered impractical and contradictive to radioembolization, which is minimally invasive. Personalised dosimetry has been demonstrated in previous studies for improved lung dosimetry (Kao et al., 2014) , as well as to investigate the response rate and survival (Garin et al., 2015a) of the HCC patients, however, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 6 both methods were still largely dependent on the PM equations. Several publications have recommended the use of Monte Carlo (MC) simulations in estimating the absorbed doses in radioembolization (Garin et al., 2015b; Kao et al., 2011; Gulec et al., 2010; Flamen et al., 2008; Kennedy et al., 2004; Sarfaraz et al., 2004) . It is expected that the MC method is more accurate in estimating the doses delivered to the tumour and surrounding healthy tissues as compared to PM, because the energy deposition in a medium is calculated without adopting any simplified assumption in terms of particle transportation. Geant4 (Allison et al., 2016; Allison et al., 2006; Agostinelli et al., 2003) has been increasingly used for the estimation of absorbed doses in nuclear medicine, with its accuracy validated through experimental measurements using physical phantoms (Ziaur et al., 2012; Meo et al., 2008) .
The aim of this study was to investigate the accuracy of the absorbed doses estimated by PM, as a result of the exclusion of cross-fire irradiation, especially between the tumour and normal liver tissue. Geant4 MC simulations were carried out and the resulting absorbed doses were compared with the doses calculated using PM. The factors that may affect the accuracy of PM estimations were determined and discussed in this study. Ho et al. (1996) and it assumes that the radioactive microspheres are distributed only in the three compartments, with no redistribution during the treatment. The model was derived from the decay data of 90 Y and, assuming a complete deposition of energy within a compartment, it depends only on the initial activity in the compartment and the compartment's total mass (Ho et al., 1996 In order to determine the activity distributed within each organ, the lung shunting (LS) and tumour-to-normal liver uptake ratio (T/N) are obtained from the pre-treatment imaging using 99m Tc-MAA (Lau et al., 1994; Leung et al., 1994) . For patients to be considered eligible for the treatment with 90 Y microspheres, the LS should not be larger than 20 %. For patients with LS of between 10 to 15 % and 15 to 20 %, the administered activities need to be reduced by 20 and 40 %, respectively (Sirtex, 2015) to limit the D L from exceeding 30 Gy. Therefore, the activity uptake in the lungs, AL is calculated using Equation 2 (Ho et al., 1996) , where, A is the administered activity. A c c e p t e d M a n u s c r i p t
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The remaining activity is assumed to be taken up by the tumour, AT and normal liver tissue, ANL as in Equation 3 (Ho et al., 1996) , with the T/N is given by Equation 4 (Ho et al., 1996) :
where, MT and MNL are the masses (kg) of the tumour and normal liver tissue, respectively.
The Geant4 Monte Carlo application
This study was carried out using the Geant4 version 9.6.p03 (Allison et al., 2006; Agostinelli et al., 2003) . As in the Geant4 advanced example human_phantom, a mathematical adult human phantom was modelled according to the MIRD Pamphlet 5
consisting of complete anatomical organs (Snyder et al., 1978) . The 70 kg MIRD-5 phantom comprises of three types of tissues namely the bone, lung and soft tissue (densities of 1.4862, 0.2958 and 0.9869g.cm -3 , respectively). The mass of each lung (right and left) and liver are 0.5 and 1.809 kg, respectively.
Computational phantom
In this study, a single tumour with similar shape as the mathematical MIRD-5 liver, located at the centre of the liver and varying in mass was considered ( Figure 1 ). The tumour mass, MT is defined by the tumour involvement, TI (%) as calculated using Equation 5:
where, ML is the mass of the liver. Additional simulations with single and multiple spherical tumours, each corresponding to 10 % TI were also carried out for comparison. These include simulations of (i) a single tumour; (ii) two tumours of equal size (2ET) with 5 % TI each; (iii) two tumours of different sizes (2DT) with 3 and 7 % TI, respectively; and (iv) four tumours A c c e p t e d M a n u s c r i p t 9 of equal size (4ET) with 2.5 % TI each. These tumours were placed with sufficient separation that the cross-fire between them was less than 1 % of the D T . This was first validated during the construction of the application, prior to the actual simulations. The surface area-tovolume ratios (S/V) for the tumours are shown in Table 1 . The liver surface area, as estimated by the MC methods is 1724.0 cm 2 ; i.e., liver S/V is 0.94 cm -1 . 
Details on the Geant4 simulation
The Low Energy Electromagnetic Package (Chauvie et al., 2004 ) was adopted to model the electromagnetic interactions, providing more accurate physics modelling at low 
Effects of various patient parameters on the absorbed dose
The effects of various TI (10, 30, 50, 70 %), T/N (1, 2.5, 5, 7.5, 10) and LS (0, 5, 10, 15, 20 %; without the reduction in the administered activity for cases where LS > 10 % as recommended by Sirtex (Sirtex, 2015) ) on the accuracy of the absorbed doses estimated by PM were investigated. The minimum and maximum values for TI and T/N were decided based on the clinical cases used in Ho et al. (1996) study, where the range of TI and T/N were 12 -65 % (mean: 39 %) and 3 -14 (but only 1/17 cases with T/N > 10; mean: 6),
respectively. In addition, Goin et al. (2005) mentioned that the ideal candidates for 90 Y radioembolization are those who do not have infiltrative HCC or bulk disease (≥ 70% tumour replacement of liver). On the other hand, patients with very small tumours are not the candidates for this treatment (Han et al., 2011) . For LS, the maximum value was chosen based on the maximum LS allowed for treatment (20%) (Sirtex, 2015) . The intervals were randomly decided according to practicality in terms of simulation time. A c c e p t e d M a n u s c r i p t 11 8 disintegrations (corresponded to 300 Bq of 90 Y) were generated for each simulation and repeated three times with different random seeds, to obtain a standard deviation of less than 1 %. The mean energy (MeV) deposited within each compartment per simulated 90 Y decay was expressed in joules (J) and divided by the mass of the compartment (kg), to obtain the absorbed dose (Gy). The results were expressed as the absorbed dose per activity uptake (mGy.MBq -1 ), by dividing each estimated dose with the activity taken up by the corresponding compartment.
Using PM, the administered activities for treatments with different parameter combinations were estimated, so to achieve either D NL lim or D L lim of 70 or 30 Gy, respectively.
From these administered activities, the activity uptake in each compartment were estimated using Equation 3. These activities were then multiplied with the absorbed dose per activity uptake values as calculated from the simulations, to obtain the actual absorbed doses received by each compartment. The absorbed doses obtained from the two methods (PM versus MC)
were compared, and the parameter combinations contributing to differences in the estimated D L and D NL were identified. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 12 3. Results
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Comparison of absorbed dose estimates (PM versus MC)
The absorbed dose per activity uptake in tumour, D T A T and normal liver, D NL A NL with various TI and T/N are shown in Table 2 A c c e p t e d M a n u s c r i p t 13 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 14 For normal liver, the relative differences for T/N of less than 2 were larger for higher TI and lower T/N by up to 12.3 %. However as T/N goes beyond 2, the relative differences drastically shift to negative values with larger differences observed for higher TI and T/N, up to a maximum difference of -78 %. From Figure 3 , we found that at T/N of approximately 2, the relative differences for all TI are equal with values of about 3 %, with respect to PM. Figure 4 shows the relative differences between the D T estimated by the two methods (with respect to PM) for various tumour models, each corresponds to a total TI of 10 %. The single sphere model showed the lowest relative differences as compared to the other models.
The single non-spherical model showed larger differences of up to 3.1 %, relative to its spherical counterpart. As the number of spheres increases, the relative differences also increase, although each model represents similar TI. For equal number of spheres but with variations in the spherical sizes (2ET versus 2DT), the results showed that there were only very minute differences (< 0.5 %) between the two models, with the 2ET model showed A c c e p t e d M a n u s c r i p t 15 slightly higher relative differences. The 4ET model showed the highest relative differences of up to 8.3 %, only slightly higher (< 0.2 %) than the differences noted for the non-spherical model. 
Implications on the absorbed dose in treatment planning
Amongst 100 simulated cases, 28 cases where the D NL estimated by MC exceeded the D NL lim were determined and are listed in Table 4 . Since PM overestimated D L by 11.7 %, the MC derived D L never exceeds D L lim . All cases in Table 4 involved LS values of equal or lower than 10 %, with most T/N of equal or larger than 5 (only 2 cases with T/N of 2.5). The mean administered activity was 8.51 ± 3.65 GBq, with minimum and maximum activity of A c c e p t e d M a n u s c r i p t 17 Table 5 compares the PM and MC based estimates of the administered activity for the cases of Table 4 , where the MC simulations would limit D NL to 70 Gy. Administered activity differences of up to 44 % were observed (case no. 23) with mean difference of 12.2 ± 10.6 %. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 18 4. Discussion PM was derived by Ho et al. (1996) (Ho et al., 1996) . (6) where, ML is the mass of the lungs. However, it should be noted that the suggested coefficient is dependent on the assumed mathematical modelling of the MIRD-5 phantom. From our study, we did not find any significant contribution of D L from the radiations in the liver as a result of the phantom geometry used in the study, where liver and lungs separation distance is larger than the maximum beta range of 90 Y (11 mm).
As mentioned in Section 2.2.1, the single spherical tumour model was limited to a maximum of 18 % TI hence, the model was not used in our study. Consequently, the attempts to incorporate multiple spherical tumours into the liver to represent TI of larger than 10 % have been carried out (up to TI of nearly 30 %), however, the efforts were restricted since extensive geometrical construction time was required in order to arrange all the spheres without interceptions between them. Also, in order to fit all the spheres into the liver, various A c c e p t e d M a n u s c r i p t 19 number of spheres and spherical sizes can be used to represent the desired TI hence, will lead to variations in the results. This is because, the decisions on how many spheres and which spherical sizes to be used are rather arbitrary. For simplicity, additional simulations to compare different tumour models have been carried out for 10 % TI, to investigate the effects of the number of spheres and their sizes towards the estimation of D T . Although the spherical tumours were purposely located towards the liver centre, the distances between them were set so that the particles that managed to escape from a sphere did not end up being absorbed by the other spheres, as mentioned in Section 2.2.1. This is to ensure that the estimation of D T is not being affected, hence the tumours can also be assumed to be located anywhere within the liver.
Even though the simulations were carried out with the tumour located at the centre of the liver, it should be noted that in real cases the tumours may as well be located at the edge of the liver. For these cases, our data on the D T may still be useful regardless of the tumour location within the liver. However, the D NL , D L and doses to the other extrahepatic tissues may be affected depending on the tumour location. We can say that for D NL , the doses will be lesser since as the tumours are located more towards the liver edges, hence the particles will be less absorbed by the normal liver but rather end up at the extrahepatic tissues. For this, the doses to the tissues should be evaluated to prepare for any complications resulting from the organ radiation toxicities. If the tissue involved is of the lung, the administered activity should be adjusted prior to treatment so that the D L does not exceed 30 Gy.
The single sphere model showed the lowest relative differences as a result of low S/V (thus, less beta particles would escape from the tumour), as compared to other models of the same mass. Hence, the estimation of D T using the model is the closest to that of PM. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 20 However, differences are still present since our MC simulations consider the cross-fire effect which is not included with PM. For the spherical models, as the S/V increases (due to increase in the number of spheres), a similar trend with the increase in the relative differences was observed. However, this is not the case when the single non-spherical model was compared with the 4ET model. Although the S/V of the 4ET model was more than two times lower than that of the single non-spherical model, the relative differences between them were almost identical (< 0.2 %). This could be as a result of the tumour shapes. Since the 4ET model consisted of separate small spheres (radius 2.22 cm), the probability of the particles to leave the spheres were higher as compared to the particles located within the non-spherical model which consisted of one bulk volume. Since the D T differences of the single nonspherical model depict that of the 4ET model, we can say that the usage of the non-spherical model for TIs other than 10 % were relevant, to represent the distribution of D T in 90 Y radioembolization of unresectable HCC.
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As shown in Section 3.1, both D T and D NL obtained by MC are dependent on the T/N which was ignored by PM, as a result of exclusion of cross-fire irradiation between the compartments. For the tumour model used in our study, larger D T overestimation by PM for lower TI was due to higher tumour S/V. Hence, for these tumours, the probability of the beta particles leaving is higher than being self-absorbed. This phenomenon also applies for the estimation of D NL where higher TI (higher normal liver S/V) results in larger D NL differences between PM and MC.
Larger D T overestimation for higher T/N was due to higher total number of beta particles leaving the tumour as compare to the lower T/N ( Figure 5 ). For lower T/N, the fraction of beta particles leaving the tumour is being compensated by the particles entering Even though the maximum difference for D T between the two methods was only up to 8 % and as shown in Table 4 ; where all D T were being overestimated by PM, this under dosing may lead to less treatment efficiency if radical approach is being aimed, especially for smaller tumours. For normal liver, it is a concern for patients with higher TI and T/N, as we found surprisingly high underestimation of D NL of up to -78 % by PM, which may cause normal liver overdose even when D NL lim was not aimed, as shown in Table 5 ) or separating the treatment in fractions, in order to promote tissue sparing of the normal liver.
Our study was done using simple model of the standard MIRD-5 human phantom so to easily understand the pattern of the physical factors that may affect the absorbed dose estimation, by manipulating the patient parameters accordingly. For wider acceptance, the term 'tumour involvement' can be changed to 'tumour replacement of liver' as used by Goin et al. (2005) and Lewandowski et al. (2006) . Although the liver model used in this study has a fixed volume, the findings can be applied to any liver volumes as long as the TI or tumour replacement of the liver correspond to similar relative value. It should be noted that in real cases, the whole liver volume may be increased as the tumour enlarged, assuming the normal 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 23 liver volume is not affected. For this case, the TI will be lower (as opposed to the fixed liver model used in our study), even though the tumours in both conditions have a similar mass.
Thus, the findings of a lower TI should be used.
Since every patient's tumour is unique (in terms of size, shape and location), the use of tomographic data may be useful to further estimates the dose to these compartments, with the incorporation of heterogeneity of both tissue and source distributions which were not considered in our study. These considerations require additional efforts in preparation of MC code input and simulation time and hence, may not be practical for clinical use. Alternatively, voxel dose kernel (VDK) (simulating radiation transport in water and applying the dose distribution map into tomographic images) can be used, to reduce the simulation time.
However, this method does not take into account the tissue inhomogeneity correction. A recent approach has been found to be able to speed up the simulation time while at the same 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 24
Conclusion
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